524412 Stock Overview
Manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Aarey Drugs & Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹55.29 |
| 52 Week High | ₹75.75 |
| 52 Week Low | ₹37.00 |
| Beta | 0.92 |
| 11 Month Change | -12.01% |
| 3 Month Change | -7.88% |
| 1 Year Change | 14.38% |
| 33 Year Change | 55.31% |
| 5 Year Change | 206.32% |
| Change since IPO | 125.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524412 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -1.0% | -0.2% | 0.3% |
| 1Y | 14.4% | 40.5% | 27.3% |
Return vs Industry: 524412 underperformed the Indian Pharmaceuticals industry which returned 40.5% over the past year.
Return vs Market: 524412 underperformed the Indian Market which returned 27.3% over the past year.
Price Volatility
| 524412 volatility | |
|---|---|
| 524412 Average Weekly Movement | 7.1% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 524412 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 524412's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | n/a | Mihir Ghatalia | www.aareydrugs.com |
Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company provides mono methyl and die methyl urea, ortho para nitro anisole, 2 bromomethyl 1, and 3 dioxalane and uracile, as well as active pharma ingredients, such as metformin HCL, mefenamic acid, and doxophylline. It also offers chemicals and solvents, including aromatic chemicals, chemical acids, chlor alkalies, glycols and glycol ethers, fiber intermediates, acetates and esters, and chlorinated solvents, as well as industrial alchols, ketones, amines, oleochemicals, intermediates, olefines, phosphates, fertilizers, monomers, and chemicals.
Aarey Drugs & Pharmaceuticals Limited Fundamentals Summary
| 524412 fundamental statistics | |
|---|---|
| Market cap | ₹1.57b |
| Earnings (TTM) | ₹60.10m |
| Revenue (TTM) | ₹5.19b |
26.1x
P/E Ratio0.3x
P/S RatioIs 524412 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524412 income statement (TTM) | |
|---|---|
| Revenue | ₹5.19b |
| Cost of Revenue | ₹5.01b |
| Gross Profit | ₹176.24m |
| Other Expenses | ₹116.14m |
| Earnings | ₹60.10m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 14, 2025
| Earnings per share (EPS) | 2.12 |
| Gross Margin | 3.40% |
| Net Profit Margin | 1.16% |
| Debt/Equity Ratio | 28.5% |
How did 524412 perform over the long term?
See historical performance and comparison